Skip To Main Content
H. J. Kang on Muck Rack

H. J. Kang

As seen in: Annals of Oncology, European Urology, Indian Journal of Pharmaceutical Sciences
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to H. J. Kang’s profile

Articles by H. J. Kang

Melatonin Inhibits Oxidized Low Density Lipoprotein Induced Proliferation and Migration of Vascular Smooth Muscle Cells and Its Mechanism

|
By C. Liu, H. J. Kang, M. Deng, J. Jin
| Indian Journal of Pharmaceutical Sciences Verified
Yang Tang1, Chuan Liu, Huali Kang, Mengyang Deng and Jun Jin* Department of Cardiology, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China 1Department of Cardiology, People’s Hospital of Chongqing Banan District, Chongqing 401320, China *Corresponding Author: Jun Jin Department of Cardiology Xinqiao Hospital Army Medical University (Third Military Medical University) Chongqing 400038, China E-mail: [email protected] Date of Received 24...
Open in Who Shared Issue with article?

Tolerability associated with sunitinib (SU) 2-week on and 1-week off schedule (2/1 schedule) compared with its standard schedule in metastatic RCC (mRCC): Meta-analysis

|
By S. Y. Lee, H. J. Kang, Pfizer Oncology
| Annals of Oncology Verified
Tolerability associated with sunitinib (SU) 2-week on and 1-week off schedule (2/1 schedule) compared with its standard schedule in metastatic RCC (mRCC): Meta-analysis H.J. Kang and S. Lee Medical Affairs Korea, Pfizer Oncology, Seoul, Republic of Korea Background: SU is the 1st line standard treatment for mRCC and it requires 4-week on treatment and 2-week off as a standard schedule for mRCC.
Open in Who Shared Issue with article?
Show More